eClinical solutions market is
expected to reach USD 10.5 billion by 2024, according to a new report published
by Grand View Research Inc. The eClinical solutions market is anticipated to
witness a lucrative growth during the period 2016 to 2024. The factors
attributing towards the growth of the market are increase in the research and
development activities by numerous biopharma and pharma companies, increasing
application of software solutions in clinical trials, upsurge in the government
funding to promote clinical research programs, rise in the number of Contract
Research Organizations (CROs) and life sciences organizations, and increasing
customer base.
Additionally, factors such as
increasing outsourcing of clinical trials to CROs, escalating clinical research
programs in Asian countries, as well as, the development of cost-effective
modules are expected to be opportunistic for the industry growth. However, the
shortage of skilled labor force, high implementation costs of the eClinical
solutions and the lack of awareness of clinical data sciences software in the
research community are likely to hinder the growth of the market in the near
future.
The eClinical solutions market
is segmented on the basis of product, delivery mode, clinical trial phase, end-user,
and region. Based on the product, the industry is categorized into clinical
analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic
Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data
integration platforms, safety solutions, Clinical Trial Management Systems
(CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial
Master File (eTMF).
The other segments of the
market include delivery mode (web-hosted, licensed enterprise, and cloud-based),
clinical trial phases (phase I, phase II, phase III, and phase IV), and
end-user application (consulting service companies, medical device
manufacturers, hospitals, contract research organizations, pharmaceutical, and
biopharmaceutical companies). On the basis of regions, the market is
categorized into North America, Europe, Asia-Pacific, Latin America, and the
Middle East and Africa).
In depth research report on eClinical Solutions Market
Further key findings from the study suggest:
·
In 2016, North America is
estimated to lead the market with the largest share in the eClinical solutions
industry. The rising number of ongoing clinical trials, high demand for
technologically advanced products, and increasing financial support from the
government is anticipated to boost the industry growth.
·
The eCOA segment is anticipated
to witness the highest growth rate during the forecast period, whereas the EDC
and CDMS segment is estimated to lead the market in the year 2016. Factors
attributing to the growth of the industry are the increasing application of
mobile and digital technologies, as well as, an upsurge in the demand for
eDiaries in clinical trials for the collection of patient’s self-reports by
pharmaceutical companies.
·
The eClinical solutions
industry comprises several local as well as global players. Some of the major
players in this industry include Oracle Corporation, Medidata Solutions Inc.,
Parexel International, Inc., and Datatrak, among others.
Grand View Research has
segmented the global eClinical solutions market on the basis of end-user
application and region:
eClinical Solutions Product Outlook (Revenue, USD Million,
2013 - 2024)
·
Electronic Data Capture (EDC)
and Clinical Data Management Systems (CDMS)
·
Clinical Trial Management
Systems (CTMS)
·
Clinical Analytics Platforms
·
Randomization and Trial Supply
Management (RTSM)
·
Clinical Data Integration
Platforms
·
Electronic Clinical Outcome
Assessment (eCOA)
·
Safety Solutions
·
Electronic Trial Master File
(eTMF)
eClinical Solutions Delivery Mode Outlook (Revenue, USD
Million, 2013 - 2024)
·
Web-hosted (On-demand)
·
Licensed Enterprise
(On-premise)
·
Cloud-based
eClinical Solutions Delivery Mode Outlook (Revenue, USD
Million, 2013 - 2024)
·
Consulting Service Companies
·
Medical Device Manufactures
·
Hospitals
·
CROs
·
Pharmaceutical
Biopharmaceutical Companies
eClinical Solutions Clinical Trial Outlook (Revenue, USD
Million, 2013 - 2024)
·
Phase I
·
Phase II
·
Phase III
·
Phase IV
eClinical Solutions Regional Outlook (Revenue, USD
Million, 2013 - 2024)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range of
industries including technology, chemicals, materials, healthcare and energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment